Clinical trial
Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure: A Prospective, Multicenter, Randomized, Open, Double-arm Clinical Trial
NCT05248022 is registered in ClinicalTrials.gov with The Central Hospital of Lishui City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure: A Prospective, Multicenter, Randomized, Open, Double-arm Clinical Trial
- Lead sponsor
- The Central Hospital of Lishui City
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2024
- Completion date
- December 31, 2024
- Enrollment
- 98 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.